Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

MET

Metlife Inc Declares Preferred Stock Dividends

Metlife, Inc. (NYSE: MET) has just declared its preferred stock dividends for the third quarter of 2025. The company announced a quarterly dividend of $0.35263005 per share on its floating rate non-cumulative preferred stock, series A, with a liquidation preference of $25 per share (NYSE: MET PRA). Additionally, a semi-annual dividend of $29.375 per share was declared on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, series D, with a liquidation preference of $1,000 per share. The quarterly dividend of $351.5625 per share on the company’s 5.625% non-cumulative preferred stock, series E, with a liquidation preference of $25,000 per share was also announced. The company's 4.75% non-cumulative preferred stock, series F, will pay a quarterly dividend of $296.875 per share. Lastly, a semi-annual dividend of $19.250 per share on the company’s 3.850% fixed rate reset non-cumulative preferred stock, series G, with a liquidation preference of $1,000 per share, has been declared.

The dividends will be payable on September 15, 2025, to shareholders of record as of Friday, August 29, 2025. This record date is due to occur on Sunday, August 31, 2025.

These announcements provide a detailed breakdown of the dividends declared for each series of preferred stock, giving investors a clear picture of the returns they can expect from their investments in Metlife, Inc. The market has reacted to these announcements by moving the company's shares -0.76% to a price of $77.33. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS